v3.26.1
Note C - Investments in Unconsolidated Entities (Tables)
12 Months Ended
Dec. 31, 2025
CB Oncology Partners ("CBOP") [Member]  
Notes Tables  
Equity Method Investments [Table Text Block]

CBOP Condensed Income Statement Information

               
                 
                 
   

Years Ended December 31,

 
                 
   

2025

   

2024

 
                 

Patient revenue

  $ 1,414,000     $ 1,475,000  
                 

Net loss

  $ (870,000 )   $ (974,000 )
                 

USNC's equity in loss of CBOP

  $ (261,000 )   $ (278,000 )

CBOP Condensed Balance Sheet Information

               
                 
   

December 31,

 
                 
   

2025

   

2024

 
                 

Current assets

  $ 348,000     $ 347,000  
                 

Noncurrent assets

    1,185,000       1,785,000  
                 

Total assets

  $ 1,533,000     $ 2,132,000  
                 

Current liabilities

  $ 4,648,000     $ 4,067,000  
                 

Noncurrent liabilities

    3,263,000       3,572,000  
                 

Deficit

    (6,378,000 )     (5,507,000 )
                 

Total liabilities and deficit

  $ 1,533,000     $ 2,132,000